BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29929438)

  • 1. Neuroprotective Effects of Cyclosporine in a Porcine Pre-Clinical Trial of Focal Traumatic Brain Injury.
    Karlsson M; Pukenas B; Chawla S; Ehinger JK; Plyler R; Stolow M; Gabello M; Hugerth M; Elmér E; Hansson MJ; Margulies S; Kilbaugh T
    J Neurotrauma; 2018 Jul; 36(1):14-24. PubMed ID: 29929438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Diffusion Tensor Imaging and Fluid Based Biomarkers in a Large Animal Trial of Cyclosporine in Focal Traumatic Brain Injury.
    Karlsson M; Yang Z; Chawla S; Delso N; Pukenas B; Elmér E; Hugerth M; Margulies SS; Ehinger J; Hansson MJ; Wang KKW; Kilbaugh TJ
    J Neurotrauma; 2021 Jun; 38(13):1870-1878. PubMed ID: 33191835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous Infusion of Phenelzine, Cyclosporine A, or Their Combination: Evaluation of Mitochondrial Bioenergetics, Oxidative Damage, and Cytoskeletal Degradation following Severe Controlled Cortical Impact Traumatic Brain Injury in Rats.
    Kulbe JR; Singh IN; Wang JA; Cebak JE; Hall ED
    J Neurotrauma; 2018 Jun; 35(11):1280-1293. PubMed ID: 29336204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A preserves mitochondrial function after traumatic brain injury in the immature rat and piglet.
    Kilbaugh TJ; Bhandare S; Lorom DH; Saraswati M; Robertson CL; Margulies SS
    J Neurotrauma; 2011 May; 28(5):763-74. PubMed ID: 21250918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Approach to Elucidate the Role of Cyclophilin D in Traumatic Brain Injury Pathology.
    Readnower RD; Hubbard WB; Kalimon OJ; Geddes JW; Sullivan PG
    Cells; 2021 Jan; 10(2):. PubMed ID: 33498273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic Mitochondria Sustain More Damage than Non-Synaptic Mitochondria after Traumatic Brain Injury and Are Protected by Cyclosporine A.
    Kulbe JR; Hill RL; Singh IN; Wang JA; Hall ED
    J Neurotrauma; 2017 Apr; 34(7):1291-1301. PubMed ID: 27596283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic window analysis of the neuroprotective effects of cyclosporine A after traumatic brain injury.
    Sullivan PG; Sebastian AH; Hall ED
    J Neurotrauma; 2011 Feb; 28(2):311-8. PubMed ID: 21142667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine as Therapy for Traumatic Brain Injury.
    Hansson MJ; Elmér E
    Neurotherapeutics; 2023 Oct; 20(6):1482-1495. PubMed ID: 37561274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury.
    Sullivan PG; Thompson MB; Scheff SW
    Exp Neurol; 1999 Nov; 160(1):226-34. PubMed ID: 10630207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-injury administration of the mitochondrial permeability transition pore inhibitor, NIM811, is neuroprotective and improves cognition after traumatic brain injury in rats.
    Readnower RD; Pandya JD; McEwen ML; Pauly JR; Springer JE; Sullivan PG
    J Neurotrauma; 2011 Sep; 28(9):1845-53. PubMed ID: 21875332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Efficiency of Cyclosporine After Traumatic Brain Injury in Rats.
    Gurcan O; Uckun MO; Celikmez RC; Turkoglu OF; Eroglu H; Beskonakli E; Oner L; Taskin Y
    Turk Neurosurg; 2020; 30(4):507-512. PubMed ID: 32672343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine A for neuroprotection: establishing dosing guidelines for safe and effective use.
    Cook AM; Whitlow J; Hatton J; Young B
    Expert Opin Drug Saf; 2009 Jul; 8(4):411-9. PubMed ID: 19548859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailored Reconstituted Lipoprotein for Site-Specific and Mitochondria-Targeted Cyclosporine A Delivery to Treat Traumatic Brain Injury.
    Chen L; Song Q; Chen Y; Meng S; Zheng M; Huang J; Zhang Q; Jiang J; Feng J; Chen H; Jiang G; Gao X
    ACS Nano; 2020 Jun; 14(6):6636-6648. PubMed ID: 32464051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?
    Sullivan PG; Rabchevsky AG; Waldmeier PC; Springer JE
    J Neurosci Res; 2005 Jan 1-15; 79(1-2):231-9. PubMed ID: 15573402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copenhagen Head Injury Ciclosporin Study: A Phase IIa Safety, Pharmacokinetics, and Biomarker Study of Ciclosporin in Severe Traumatic Brain Injury Patients.
    Kelsen J; Karlsson M; Hansson MJ; Yang Z; Fischer W; Hugerth M; Nordström CH; Åstrand R; Keep MF; Kilbaugh T; Wang KKW; Møller K; Juhler M; Elmér E
    J Neurotrauma; 2019 Dec; 36(23):3253-3263. PubMed ID: 31210099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury.
    Sullivan PG; Thompson M; Scheff SW
    Exp Neurol; 2000 Feb; 161(2):631-7. PubMed ID: 10686082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of new and novel pharmacotherapies for use in traumatic brain injury.
    Vink R; Nimmo AJ; Cernak I
    Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):919-21. PubMed ID: 11703396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial neuroprotection in traumatic brain injury: rationale and therapeutic strategies.
    Yokobori S; Mazzeo AT; Gajavelli S; Bullock MR
    CNS Neurol Disord Drug Targets; 2014; 13(4):606-19. PubMed ID: 24168363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy.
    Singh IN; Sullivan PG; Deng Y; Mbye LH; Hall ED
    J Cereb Blood Flow Metab; 2006 Nov; 26(11):1407-18. PubMed ID: 16538231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence to support mitochondrial neuroprotection, in severe traumatic brain injury.
    Gajavelli S; Sinha VK; Mazzeo AT; Spurlock MS; Lee SW; Ahmed AI; Yokobori S; Bullock RM
    J Bioenerg Biomembr; 2015 Apr; 47(1-2):133-48. PubMed ID: 25358440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.